News

HOME > Media > News
Notice
KDDF hosts the second global Connection & Development Tech Fair 01.02.2017

KDDF hosts the second global Connection & Development Tech Fair

 

(A full view of the showcase)

Korea Drug Development Fund (KDDF) hosted its second “2016 KDDF Global Connection & Development Tech-Fair” event at The-K Hotel Seoul on December 6th, following its first event in January.

 

A total of 203 visitors, including government officials and pharmaceutical researchers, participated in the event. Six people from 5 foreign organizations showcased their entities via introductory materials and handouts, while one-on-one partnering sessions with foreign biotech experts and venture capitalists (VC) were also arranged.

(Welcome address from Joo Sang-aun, CEO of KDDF)

 

In the welcome address opening the December event, Sang-sun Joo, the CEO of KDDF, emphasized the importance of the open-innovation based sourcing programs for the development of many drug candidates and first-generation technologies. Following this, congratulatory speeches followed by Jung Byung-sun (Director of the Basic Research Policy Bureau of the Ministry of Science, ICT, and Future Planning) and Jung Young-gi (Assistant Director of the Health and Medical Science Technology Development Department of the Ministry of Health and Welfare).

 

The tech-fair was aimed at providing an opportunity for local R&D institutions looking for in-licensing and investment potentials to hone their competitive edge and to find new business opportunities. As a result, a total of 28 partnering sessions and a number of VC consulting sessions have taken places.

 

(40 posters on display in the exhibition lobby)

 

In addition, experts evaluated 217 compounds through individual review and discussion process and selected 40 first-in-class drug candidates; posters of these most-promising candidates were displayed in the exhibition lobby. After completion of the event, KDDF endeavored to facilitate the sustained partnership between Korean companies and those foreign companies having the promising pipelines.

 

The poster sessions drew keen interest from many Korean companies. Ten companies made 35 inquiries about specific compounds portrayed in 40 posters, and other firms requested detailed information on 24 compounds owned by 17 foreign companies.

 

Attachments
list
Update to 2013 © KOREA DRUG DEVELOPMENT FUND. ALL RIGHTS RESERVED. QR Code